A Study of XL184 (Cabozantinib) With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer

Georgetown University/Lombardi Comprehensive Cancer Center, Washington D.C.

Case Western Reserve University, Cleveland

Park Nicollet Institute, Saint Louis Park

University of Chicago Medical Center, Chicago

MD Anderson Cancer Center, Houston

Stanford University Medical Center, Palo Alto

University of California, Davis, Sacramento

Swedish Cancer Institute, Seattle

University of Washington/ Seattle Cancer Care Alliance, Seattle

Katmai Oncology Group, Anchorage

Yale University School of Medicine, New Haven

Dana Farber Cancer Institute, Boston

Summit Medical Group, Berkeley Heights